Latest Food & Drug Administration news
In Rare Move, FDA Panel Gives Support to Controversial ALS Drug in Second Review
posted September 8th
by modernClinician Editorial Team
by modernClinician Editorial Team
FDA Approves SPEVIGO for Generalized Pustular Psoriasis Flares
posted September 6th
by modernClinician Editorial Team
by modernClinician Editorial Team
FDA Approves First Treatment for Acid Sphingomyelinase Deficiency
posted September 2nd
by modernClinician Editorial Team
by modernClinician Editorial Team
FDA Warns of Dangers From Skin-Lightening Creams
posted September 1st
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
Hydrogel-Based Dermal Regenerative Template Shows Promise in Wound Reconstruction 
Nearly 2 in 3 Poison Exposures in Young Children May Not Need the ED 
Unintentional Ingestion of Recreational Drugs Increased, Especially Since 2013 
Considerable Global Disparities Found in Access to Dermatological Care 
FDA Now Providing Daily Updates on Adverse Events 
FDA Suspends U.S. License of Chikungunya Vaccine 
FDA Urges Restrictions, Education on Illegal 7-OH Opioid Products 
Federal Agencies Working to Create Uniform Definition of Ultra-Processed Foods Monthly Specialist Briefings
Stay Connected
